Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah V Novack

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cell Reports|January 4, 2016
Stromal-Initiated Changes in the Bone Promote Metastatic Niche DevelopmentXianmin Luo, Yujie Fu, Andrew J Loza, et al.
The Journal of Clinical Investigation|September 22, 2012
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodelingXinming Su, Desiree H Floyd, Alun Hughes, et al.
Cancer Research|September 1, 2017
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer MetastasesMichael H Ross, Alison K Esser, Gregory C Fox, et al.
Cancer Research|May 25, 2016
Antagonizing Integrin β3 Increases Immunosuppression in CancerXinming Su, Alison K Esser, Sarah R Amend, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cell Reports|January 4, 2016
Stromal-Initiated Changes in the Bone Promote Metastatic Niche DevelopmentXianmin Luo, Yujie Fu, Andrew J Loza, et al.
The Journal of Clinical Investigation|September 22, 2012
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodelingXinming Su, Desiree H Floyd, Alun Hughes, et al.
Cancer Research|September 1, 2017
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer MetastasesMichael H Ross, Alison K Esser, Gregory C Fox, et al.
Cancer Research|May 25, 2016
Antagonizing Integrin β3 Increases Immunosuppression in CancerXinming Su, Alison K Esser, Sarah R Amend, et al.
Pageof 6